Partner Content Partner Content GSK explores Oral Lipid Based Formulations & Taste Maski... GSK explores Oral Lipid Based Formulations
Partner Content Partner Content Ipsen presents on oral peptides innovations, advances and de... Ipsen presents on oral peptides innovations & delivery
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
Events Partner Content Controlled Release Delivery 2018 15th annual Controlled Release Delivery in London
News Immutep investors spooked by LAG-3 failure in lung cancer Friday the 13th has turned into a horror story for Immutep, whose share price has collapsed after it abandoned a pivotal trial of its LAG-3 drug efti.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
